Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Former Air Force Captain appointed by Crowd Media for commercialisation takeoff
    • News

    Former Air Force Captain appointed by Crowd Media for commercialisation takeoff

    President of the United States, Royal Family and now Crowd Media (ASX: CM8). It may not be a linear progression but the disruptive artificial intelligence company is following the time-tested trend of appointing an exceptional military leader to drive its next phase of growth with Idan Schmorak confirmed as its new CEO.  A former officer

    Read More
    Public
  • Bendigo and Adelaide Bank to expand quickfire home loans with Ferocia fintech acquisition
    • News

    Bendigo and Adelaide Bank to expand quickfire home loans with Ferocia fintech acquisition

    With house prices across Australia continuing to soar, the market for home loans is heating up as the major banks seek to capture the younger tech-savvy generation with Bendigo and Adelaide Bank (ASX: BEN) confirming their acquisition of fintech business Ferocia for $116 million. The acquisition is driven by Bendigo Bank’s response to changes in

    Read More
    Public
  • West Virginia… mountain mama… Take me home, to get my bet on…
    • News

    West Virginia… mountain mama… Take me home, to get my bet on…

    Country roads, take me home, to the place I belong, West Virginia…. mountain mama, Take me home, to get my bet on… A slight tweak to the John Denver classic could soon be a new theme song for the Mountain State with bookmaker PointsBet (ASX: PBH) securing regulatory approval to commence its sports betting operations

    Read More
    Public
  • Cancer drug development company gathering momentum as more researchers worldwide take notice
    • News

    Cancer drug development company gathering momentum as more researchers worldwide take notice

    With promising data starting to flow from clinical trials, more and more medical researchers are tuning in to the Pharmaxis (ASX: PXS) story. The drug development Company has a diverse pipeline backed by solid science with drugs engineered by their world renowned drug development team. Lead drug candidate PXS-5505 is designed to treat myelofibrosis, aRead More
    Public
  • Unanimous Board support for merger to create vocational education giant
    • News

    Unanimous Board support for merger to create vocational education giant

    The new kids on the block in the higher education sector continue to make waves at a time when their traditional rivals are being forced to slash jobs with confirmation that the proposed merger of iCollege (ASX: ICT) and RedHill Education (ASX: RDH) has received unanimous support from both Board of Directors. The merger will

    Read More
    Public
  • Blood test or crystal ball? Looking into the future of our health
    • News

    Blood test or crystal ball? Looking into the future of our health

    An estimated 1.2 million Australians are living with diabetes, a serious chronic disease with numerous complications and comorbidities including diabetic kidney disease (DKD). The risk factors for developing DKD are well known, but could we treat people better if we knew more about their personal risk factors, or predict the likelihood of future functional decline

    Read More
    Public
  • «
  • ‹
  • 471
  • 472
  • 473
  • 474
  • 475
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.